Recombinant Proteins
- (285)
- (11)
- (66,342)
- (1)
- (2)
- (970)
- (1)
- (23,540)
- (5)
- (1)
- (1)
- (67)
- (370)
- (4,450)
- (23)
- (1)
- (4)
- (2)
- (13)
- (21,446)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (71)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (157)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (253)
- (23,062)
- (1)
- (1)
- (2)
- (1)
- (13)
- (26,800)
- (406)
- (32)
- (3)
- (708)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (105)
- (1)
- (3,750)
- (1,407)
- (3)
- (4)
- (5)
- (1)
- (1)
- (1)
- (1)
- (14)
- (138)
- (48)
- (6)
- (17)
- (2)
- (1)
- (10)
- (4)
- (81)
- (12)
- (2)
- (3)
- (80)
- (4)
- (113)
- (96)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,522)
- (2)
- (1)
- (160)
- (18)
- (48)
- (3)
- (3)
- (1)
- (2)
- (9)
- (27)
- (2)
- (510)
- (1)
- (4)
- (1)
- (2)
- (114)
- (44)
- (2)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (23,708)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (1)
- (6,758)
- (6)
- (4)
- (1)
- (3)
- (1)
- (3)
- (2)
- (13)
- (17)
- (1)
- (3)
- (3)
- (4)
- (27,095)
- (235)
- (1)
- (3)
- (2)
- (1)
- (2)
- (1)
- (89)
- (559)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (27)
- (1)
- (8)
- (15)
- (1)
- (72)
- (1)
- (1,303)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (4)
- (1)
- (1)
- (29,092)
- (5)
- (22)
- (8)
- (4)
- (1,291)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (8)
- (14)
- (32)
- (24)
- (1)
- (2)
- (16)
- (233)
- (9)
- (2)
- (5)
- (1)
- (2)
- (2)
- (2)
- (23)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,574)
- (1)
- (48)
- (15)
- (1)
- (2)
- (45,210)
- (6,120)
- (245)
- (168)
- (56)
- (3,361)
- (7)
- (1)
- (3)
- (18)
- (2)
- (62)
- (1)
- (4)
- (2)
- (9)
- (60)
- (1)
- (2)
- (3)
- (1)
- (417)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (2)
- (3)
- (19)
- (7)
- (2)
- (2)
- (3)
- (45)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (1)
- (2)
- (8)
- (2)
- (3)
- (43,546)
- (1)
- (11)
Filtered Search Results
| Content And Storage | -20°C, Avoid Freeze/Thaw Cycles |
|---|---|
| Purity or Quality Grade | >95% as determined by SDS-PAGE. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CD16 |
| Molecular Weight (g/mol) | 40-45 kDa |
| Gene Symbol | FCGR3A, FCGR3B |
| Activity | Measured by its binding ability in a functional ELISA. Immobilized CD16a-His at 2 μg/ml (100 μL/well) can bind human IgG1, the EC50 of human IgG1 is 200-600 ng/mL. |
| Endotoxin Concentration | <1.0 EU/μg |
| Sequence | Human CD16a, amino acids Met1-Gln208 (Accession # P08637-1, with natural variant Phe 176 Val) with a C-terminal His-tag |
| Expression System | CHO cells |
| For Use With (Application) | Control,ELISA Standard,Binding Assay |
| Name | Human Fc gamma RIIIA (CD16a) (176 Val) His-tag |
| Accession Number | O75015, P08637 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | 4833442P21Rik; CD16; CD16-2; CD16A; CD16a antigen; CD16b; CD32; CD32 receptor 2; CDw32; cytolytic trigger molecule G7; Fc fragment of IgG intermediate affinity IV receptor; Fc fragment of IgG low affinity IIIa receptor; Fc fragment of IgG receptor IIIa; Fc fragment of IgG receptor IIIb; Fc fragment of IgG, low affinity III, receptor for (CD16); Fc fragment of IgG, low affinity IIIa, receptor; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); Fc fragment of IgG, low affinity IIIa, receptor for (CD16); Fc fragment of IgG, low affinity IIIa, receptor for (CD16); Fc fragment of IgG, low affinity III, receptor for (CD16); Fc fragment of IgG, low affinity IIIb, receptor (CD16b); Fc gamma receptor III; Fc gamma receptor IIIa; Fc gamma receptor III-A; Fc gamma receptor IIIb; Fc gamma RIIIa; Fc gammaRIV; Fc receptor, IgG, low affinity III; Fc receptor, IgG, low affinity IV; Fc receptor-like 3; Fcg receptor III; FCG2; FCG3; Fc-gamma receptor III-2 (CD 16); Fc-gamma receptor IIIb (CD 16); Fc-gamma receptor IIIb (CD16); Fc-gamma RII-b; Fc-gamma RII-c; fc-gamma RIII; Fc-gamma RIIIa; Fc-gamma RIII-alpha; fc-gamma RIIIb; fc-gamma RIII-beta; Fc-gamma-RIIb; Fc-gamma-RIIc; FcgammaRIII; FcgammaRIII a.1; FcgammaRIII a.2; FcgammaRIII a.3; FcgammaRIIIA; FcgammaRIV; FCGR2; FCGR2A; FCGR2B; FCGR2C; FCGR3; Fcgr3a; FCGR3B; Fcgr4; FCGRIII; FcgRIV; FcR-10; FcRII-b; FcRII-c; FcRIII; FCRIIIA; FCRIIIb; Fcrl3; IGFR3; IgG Fc gamma receptor III; igG Fc receptor III; IgG Fc receptor III-1; igG Fc receptor III-2; IMD20; immunoglobulin G Fc receptor III; LOC100911825; Low affinity immunoglobulin gamma Fc region receptor III; low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; low affinity immunoglobulin gamma Fc region receptor III-like; Low affinity immunoglobulin gamma Fc region receptor IV; neutrophil-specific antigen NA; RP11-5K23.1; transmembrane receptor FcgammaRIII-X |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Measured by its binding ability in a functional ELISA. Immobilized CD16a-His (at 2 μg/ml (100 μL/well) can bind human IgG1, the EC50 of human IgG1 is 200-600 ng/mL) |
| Gene ID (Entrez) | 2214, 2215 |
| Formulation | PBS with 5% mannitol, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
| Content And Storage | -20°C, Avoid Freeze/Thaw Cycles |
|---|---|
| Purity or Quality Grade | >95% as determined by SDS-PAGE. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CD33 |
| Molecular Weight (g/mol) | 53.5 kDa |
| Gene Symbol | CD33 |
| Endotoxin Concentration | <1.0 EU/μg |
| Sequence | Human CD33, amino acids Met1-His259 (Accession # AAH28152.1) with a C-terminal human IgG1 Fc region |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,Neutralization |
| Name | Human Siglec-3 (CD33) Fc Chimera |
| Accession Number | P20138 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | CD33; CD33 antigen; CD33 antigen (gp67); CD33 molecule; CD33 molecule transcript; FLJ00391; gp67; Myeloid cell surface antigen CD33; p67; sialic acid binding Ig-like lectin 3; sialic acid-binding Ig-like lectin 3; SIGLEC3; Siglec-3 |
| Format | Lyophilized |
| Product Type | Protein |
| Gene ID (Entrez) | 945 |
| Formulation | PBS with 0.01% mannitol, 5-8% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Protein Tag | Fc-tag |
| Recombinant | Recombinant |
| Content And Storage | -20°C, Avoid Freeze/Thaw Cycles |
|---|---|
| Purity or Quality Grade | ≥90% as determined by SDS-PAGE. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CD19 |
| Molecular Weight (g/mol) | 31.56 kDa |
| Gene Symbol | Cd19 |
| Activity | Immobilized Human CD19 His at 2 μg/ml (100 μL/well) can bind Anti-CD19 Antibody, the EC50 of Anti-CD19 Antibody is 8-24 ng/mL. |
| Endotoxin Concentration | <1.0 EU/μg |
| Sequence | Human CD19, amino acids Met1-Lys291 (Accession # P15391-1) with a C-terminal His-tag |
| Concentration | 0.25 mg/mL |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,ELISA Standard,Binding Assay |
| Name | Human CD19 His-tag |
| Accession Number | P15391 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | AW495831; B4; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Cd19; CD19 antigen; CD19 molecule; CVID3; differentiation antigen CD19; Leu-12; T-cell surface antigen Leu-12 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Immobilized Human CD19 His (at 2 μg/ml (100 μL/well) can bind Anti-CD19 Antibody, the EC50 of Anti-CD19 Antibody is 8-24 ng/mL) |
| Gene ID (Entrez) | 930 |
| Formulation | PBS with 5% mannitol, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
| Regulatory Status | RUO |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions |
| Conjugate | Unconjugated |
| Form | Liquid |
| Molecular Weight (g/mol) | 21.88 kDa |
| Formulation | Laemmli with no preservative; pH 6.8 |
| Sequence | Amino acids Ala117-Ser269 containing an N-terminal His-tag |
| Concentration | 0.05 mg/mL |
| For Use With (Application) | Control,Western Blot |
| Source | E. coli |
| Name | Human IL-1 beta |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human Vimentin Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
R&D Systems™ Recombinant Human B7-2/CD86 Fc Chimera Protein
A New rh B7-2 is Available! It has higher purity, ∼3 fold better activity, and is HEK293 expressed!
R&D Systems™ Recombinant Mouse Ephrin-A5 Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human Acetylcholinesterase/ACHE Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Human VEGF-C (Cys156Ser) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity, Binding Activity
| Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | Observed Molecular Wt: 22-24kDa, reducing conditions, Predicted Molecular Wt.: 15.4kDa |
| Gene ID (Entrez) | 7424 |
| Quantity | 25 μg |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Mouse myeloma cell line,NS0-derived human VEGF-C protein Thr103-Arg227 (Cys156Ser),with a C-terminal 10-His tag |
| Recombinant | Recombinant |
| Name | VEGF-C (Cys156Ser) |
R&D Systems™ Recombinant Mouse Carboxylesterase 1/CES1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Mouse IL-17A (CHO-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.